A federal judge in Texas ruled that three states can challenge the current rules of accessibility for abortion pills.
Idaho, Kansas and Missouri requested late last year to pursue the case in federal court in Amarillo, Texas, after the U.S. Supreme Court ... so his administration will likely be representing the FDA in the case. Trump has repeatedly said abortion is ...
Instead of dismissing the case, Judge Matthew Kacsmaryk said three states with no connection to Texas can sue the FDA to try to reimpose restrictions on mifepristone.
The Trump-appointed federal judge who unilaterally ordered the FDA to revoke approval of an abortion drug allowed Idaho, Kansas and Missouri to move forward in another lawsuit over mifepristone.
a federal judge in Texas ruled on Thursday. U.S. District Judge Matthew Kacsmaryk in Amarillo decided that the three states can continue their case against the U.S. Food and Drug Administration in his court, where they last year joined a lawsuit originally ...
Rather than target the approval entirely, they sought to undo a series of FDA updates that have eased ... the request in U.S. District Court in Amarillo, Texas. The only judge based there is ...
Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit the FDA from allowing online prescriptions.
Rather than target the approval entirely, they sought to undo a series of FDA updates that have eased access ... Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas. The only judge based there is Matthew Kacsmaryk, a nominee ...
Mrs. Porsha Evette Ngumezi, 35 passed away at Houston Methodist Hospital in Sugarland, TX on June 12, 2023.” So reports the All Families Mortuary. What
A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that its manufacturing process violates safety regulations. The U.S. Food & Drug Administration sent a warning letter to Frontier Biologics in November, outlining concerns about the company’s operations.
Lab-developed tests (LDTs) are laboratory tests where blood is drawn and placed in a test tube to help with identification, diagnosis, and treatment of diseases, conditions, and infections. Examples of LDTs are the COVID-19 test,